FDA Approval of Tislelizumab
Rahul Gosain, MD, MBA; Rohit Gosain, MD; and Anwaar Saeed, MD, evaluate the RATIONALE-305 and RATIONALE-306 trials, investigating tislelizumab and examining the trials’ key end points, including overall survival, progression-free survival, and safety outcomes.
